-
1
Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia
Published 2022-08-01Subjects: Get full text
Article -
2
Demethyleneberberine alleviated the inflammatory response by targeting MD-2 to inhibit the TLR4 signaling
Published 2023-04-01Subjects: Get full text
Article -
3
Nicotine and its metabolite cotinine target MD2 and inhibit TLR4 signaling
Published 2021-05-01Subjects: Get full text
Article -
4
ACT001 Inhibits TLR4 Signaling by Targeting Co-Receptor MD2 and Attenuates Neuropathic Pain
Published 2022-06-01Subjects: Get full text
Article -
5
Antimicrobial peptides could antagonize uncontrolled inflammation via Toll-like 4 receptor
Published 2022-12-01Subjects: Get full text
Article -
6
-
7
The interaction of MD-2 with small molecules in huanglian jiedu decoction play a critical role in the treatment of sepsis
Published 2022-09-01Subjects: Get full text
Article